-

Rite Aid Completes Restructuring Process and Emerges from Chapter 11

Moving Forward as a Stronger Company with Focused Portfolio and Enhanced Financial Position

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (“Rite Aid” or the “Company”) today announced that it has successfully completed its financial restructuring and emerged from Chapter 11, marking a new beginning as a stronger company with a rightsized store footprint, more efficient operating model, significantly less debt and additional financial resources.

“Emergence is a pivotal moment in Rite Aid’s history, enabling it to move forward as a significantly transformed, stronger and more efficient company,” said Jeffrey S. Stein, Chief Executive Officer and Chief Restructuring Officer. “We are grateful for the ongoing support of our customers, associates and partners, and we look forward to continuing to provide leading pharmacy services designed to improve health and wellness outcomes across the communities we serve. I am excited about Rite Aid’s future as it continues to focus on executing its strategy and delivering for its customers and stakeholders.”

Through this process, Rite Aid has eliminated approximately $2.0 billion of total debt. Additionally, the Company has received approximately $2.5 billion in exit financing to support the business going forward.

In connection with emergence, Rite Aid will operate as a private company. Ownership of the Company transitioned to certain Rite Aid creditors, and all of Rite Aid’s existing common shares were cancelled, pursuant to the Plan of Reorganization.

Separately, Rite Aid today announced that Matt Schroeder, who most recently served as Chief Financial Officer, has been appointed Chief Executive Officer. He succeeds Mr. Stein, who joined the Company as Chief Executive Officer and Chief Restructuring Officer to lead the court-supervised Chapter 11 process.

Kirkland & Ellis LLP served as Rite Aid’s legal advisor, Guggenheim Securities, LLC as investment banker and Alvarez & Marsal as transformation officer and financial advisor to the Company.

About Rite Aid

Rite Aid is a full-service pharmacy committed to improving health outcomes. Rite Aid is defining the modern pharmacy by meeting customer needs with a wide range of solutions that offer convenience, including retail and delivery pharmacy, as well as services offered through the Company’s wholly owned subsidiary Bartell Drugs. For more information, please visit www.riteaid.com.

Contacts

MEDIA:
Tilda Comstock
(412) 310-1143
press@riteaid.com

Rite Aid Corporation

OTC Pink:RADCQ

Release Versions

Contacts

MEDIA:
Tilda Comstock
(412) 310-1143
press@riteaid.com

More News From Rite Aid Corporation

Rite Aid Corporation Names Matt Schroeder as Chief Executive Officer

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (“Rite Aid” or the “Company”) today announced that Matt Schroeder has been appointed Chief Executive Officer after the Company’s emergence from Chapter 11. Mr. Schroeder joined Rite Aid in 2000 and most recently served as the Company’s Chief Financial Officer. He succeeds Jeffrey S. Stein, who has stepped down as Chief Executive Officer and Chief Restructuring Officer in connection with the Company’s emergence from Chapter 11. “Matt has served...

Rite Aid Enters into Agreement to Divest Majority of Health Dialog Assets

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced that it has entered into an asset purchase agreement (“APA”) for the partial sale of its Health Dialog business to Carenet Health (“Carenet”), a provider of healthcare engagement, clinical support, telehealth and advocacy solutions. Health Dialog provides personalized population health solutions to improve the health of members while reducing overall medical costs for companies and org...

Rite Aid Completes Sale of Elixir Solutions to MedImpact

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Company”) today announced it has completed the previously announced sale of its Elixir Solutions business (“Elixir”) to MedImpact Healthcare Systems, Inc. (“MedImpact”) for approximately $576.5 million. “We are pleased to finalize the sale of Elixir, marking another important milestone in our transformation to strengthen our long-term financial position,” said Jeffrey S. Stein, Rite Aid’s CEO and Chief Restruct...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.